These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7989488)

  • 61. Comparison of a radioimmunoassay with a microparticle enzyme immunoassay of insulin for use with the minimal model method of determining whole-body insulin sensitivity.
    Rood JC; Lovejoy JC; Tulley RT
    Diabetes Technol Ther; 1999; 1(4):463-8. PubMed ID: 11474834
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clustering of cardiovascular risk factors in confirmed prehypertensive individuals.
    Haffner SM; Ferrannini E; Hazuda HP; Stern MP
    Hypertension; 1992 Jul; 20(1):38-45. PubMed ID: 1618551
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Association between proinsulin, insulin, proinsulin/insulin ratio, and insulin resistance status with the metabolic syndrome.
    Pivatto I; Bustos P; Amigo H; Acosta AM; Arteaga A
    Arq Bras Endocrinol Metabol; 2007 Oct; 51(7):1128-33. PubMed ID: 18157389
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Dissimilar association of conventional immuno-reactive versus specific insulin with cardiovascular risk factors: a consequence of proinsulinaemia?
    Grootenhuis PA; Mooy JM; Kostense PJ; Popp-Snijders C; Bouter LM; Heine RJ
    Diabetes Res Clin Pract; 1998 May; 40(2):81-90. PubMed ID: 9681273
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Increased β-Cell Workload Modulates Proinsulin-to-Insulin Ratio in Humans.
    Mezza T; Ferraro PM; Sun VA; Moffa S; Cefalo CMA; Quero G; Cinti F; Sorice GP; Pontecorvi A; Folli F; Mari A; Alfieri S; Giaccari A
    Diabetes; 2018 Nov; 67(11):2389-2396. PubMed ID: 30131390
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Significant association of insulin and proinsulin with clustering of cardiovascular risk factors.
    Jia EZ; Yang ZJ; Chen SW; Qi GY; You CF; Ma JF; Zhang JX; Wang ZZ; Qian WC; Li XL; Wang HY; Ma WZ
    World J Gastroenterol; 2005 Jan; 11(1):149-53. PubMed ID: 15609415
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Birth weight and the metabolic syndrome: thrifty phenotype or thrifty genotype?
    Stern MP; Bartley M; Duggirala R; Bradshaw B
    Diabetes Metab Res Rev; 2000; 16(2):88-93. PubMed ID: 10751748
    [TBL] [Abstract][Full Text] [Related]  

  • 68. High proinsulin concentration precedes acute myocardial infarction in a nondiabetic population.
    Lindahl B; Dinesen B; Eliasson M; Røder M; Jansson JH; Huhtasaari F; Hallmans G
    Metabolism; 1999 Sep; 48(9):1197-202. PubMed ID: 10484064
    [TBL] [Abstract][Full Text] [Related]  

  • 69. 'True' fasting serum insulin level, insulin resistance syndrome and coronary artery disease.
    Chaour M; Théroux P; Gilfix BM; Campeau L; Lespérance J; Ghitescu M; Gélinas F; Solymoss BC
    Coron Artery Dis; 1997; 8(11-12):683-8. PubMed ID: 9472456
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dynamic changes in plasma proinsulin/insulin ratio during insulin secretion influence correlation between radioimmunoassay (RIA) and IMX measurements of insulin.
    Stickle DF; Reynolds MA; Morris MD; Quon MJ
    Clin Chim Acta; 1999 Jun; 284(1):1-13. PubMed ID: 10437638
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Heart rate in relation to insulin sensitivity and insulin secretion in nondiabetic subjects.
    Festa A; D'Agostino R; Hales CN; Mykkänen L; Haffner SM
    Diabetes Care; 2000 May; 23(5):624-8. PubMed ID: 10834420
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Beyond type 2 diabetes: the need for a clinically useful way to identify insulin resistance.
    McLaughlin TL; Reaven GM
    Am J Med; 2003 Apr; 114(6):501-2. PubMed ID: 12727584
    [No Abstract]   [Full Text] [Related]  

  • 73. Insulin resistance, hyperinsulinemia, dyslipidemia, hypertension, and accelerated atherosclerosis.
    Sowers JR
    J Clin Pharmacol; 1992 Jun; 32(6):529-35. PubMed ID: 1634639
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Metabolic precursors of hypertension. The San Antonio Heart Study.
    Haffner SM; Miettinen H; Gaskill SP; Stern MP
    Arch Intern Med; 1996 Sep; 156(17):1994-2001. PubMed ID: 8823152
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Insulin propeptides in conditions associated with insulin resistance in humans and their relevance to insulin measurements.
    Proudler AJ; Godsland IF; Stevenson JC
    Metabolism; 1994 Apr; 43(4):446-9. PubMed ID: 8159101
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Analysis of data on insulin resistance from the European group for the study of insulin resistance: focus on obesity and hypertension.
    Ferrannini E
    Endocr Pract; 2003; 9 Suppl 2():43-9. PubMed ID: 14698975
    [No Abstract]   [Full Text] [Related]  

  • 77. Low nutrient intake and early growth for later insulin resistance in adolescents born preterm.
    Singhal A; Fewtrell M; Cole TJ; Lucas A
    Lancet; 2003 Mar; 361(9363):1089-97. PubMed ID: 12672313
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Fasting proinsulin levels are significantly associated with 20 year cancer mortality rates. The Hoorn Study.
    Walraven I; van 't Riet E; Stehouwer CD; Polak BC; Moll AC; Dekker JM; Nijpels G
    Diabetologia; 2013 May; 56(5):1148-54. PubMed ID: 23460020
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Insulin and cardiovascular disease: biomarker or association?
    Jandeleit-Dahm KA; Gray SP
    Diabetologia; 2012 Dec; 55(12):3145-51. PubMed ID: 23052054
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Hyperproinsulinemia in obesity and in type 2 diabetes and its relation to cardiovascular disease.
    Røder ME
    Expert Rev Endocrinol Metab; 2017 Jul; 12(4):227-239. PubMed ID: 30058886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.